Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis-Reference-Cited by-同舟云学术

Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis

Published:2020-01 Issue: Volume:37 Page:101431
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Erdal Julie Laub^ORCID,Kopp Tine Iskov^ORCID,Blinkenberg Morten,Petersen Thor,Sørensen Per Soelberg,Magyari Melinda

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference33 articles.

1. Prevalence and familial incidence of disseminated sclerosis (a report to the Northern Ireland hospitals board on the results of a three year study);Allison;Ulster Med. J.,1954

2. Pediatric multiple sclerosis: a review;Alroughani;BMC Neurol.,2018

3. Safety and efficacy of delayed-release dimethyl fumarate in pediatric patients with relapsing multiple sclerosis (FOCUS);Alroughani;Pediatr Neurol,2018

4. Cognitive and psychosocial features of childhood and juvenile MS;Amato;Neurology,2008

5. Pediatric multiple sclerosis: cognition and mood;Amato;Neurology,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Old and New Strategies in the Treatment of Pediatric Multiple Sclerosis: A Personal View for a New Treatment Approach;Neurology and Therapy;2024-06-01

2. Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis;JAMA Neurology;2024-03-01

3. Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple Sclerosis;Neurology;2023-11-07

4. Treatments of paediatric multiple sclerosis: Efficacy and tolerance in a longitudinal follow-up study;European Journal of Paediatric Neurology;2023-07

5. Narrative review based on fingolimod therapy in pediatric MS;SAGE Open Medicine;2023-01